Japan first nation to approve Novartis psoriasis drug
Swiss pharmaceutical company Novartis said Friday it has won approval to market its Cosentyx psoriasis treatment in Japan, making it the first country to authorise commercialisation of the drug.
Dec 26, 2014
0
0